The term "alcohol and drug addiction therapy" is used to refer to a broad variety of therapies that treat substance abuse disorders or deal with drug usage patterns. Some forms of treatment directly target addiction and offer coping skills to prevent you from relapsing when faced with cravings and triggers. These treatments frequently focus on assisting you in developing relapse prevention techniques that you may use to protect your recovery. Other treatments could concentrate on underlying problems that might exacerbate or worsen a drug use disorder. For instance, drinking and trauma are frequently linked. It may be required to utilise counselling techniques that explicitly target illnesses like post-traumatic stress, such as eye movement desensitisation and reprocessing, to treat alcoholism in a person who has suffered trauma (EMDR therapy). Substantial proof therapies and alternative therapies are the other two divisions that may be made for addiction therapy. Research backs up evidence-based therapy, but alternative therapies haven't been studied and may appear to work in some therapeutic circumstances. Although treatment strategies should be based on research, there may be instances where alternative therapies are appropriate.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States